Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-022492
Filing Date
2019-04-02
Accepted
2019-04-02 16:29:01
Documents
2
Period of Report
2019-03-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2868
2 POA DOCUMENT poa.txt EX-24.3_845545 2094
  Complete submission text file 0001209191-19-022492.txt   6383
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACADIA PHARMACEUTICALS INC. 3611 VALLEY CENTRE DRIVE, SUITE 300 SAN DIEGO CA 92130
Business Address
Ridloff Elena (Reporting) CIK: 0001772518 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50768 | Film No.: 19725353